Montreal Heart Institute Foundation
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
C-
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
77%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 77 cents are available for programs.
My anchor
OVERVIEW
About Montreal Heart Institute Foundation:
Montreal Heart Institute Foundation is a 2-star rated charity. It has below average disclosure with a C- results reporting grade. Its overhead spending and funding reserves are within Ci’s reasonable range.
Founded in 1977, Montreal Heart Institute Foundation (MHI Foundation) raises money for the Montreal Heart Institute (MHI). MHI is a specialized cardiac hospital and research centre based in Montreal. It focuses on heart disease research, patient care, prevention, and education.
MHI Foundation states that heart disease is the leading cause of death in Canada. Every year, 25,000 Canadian women suffer a heart attack. Heart failure affects 3.2% of Quebecers. Despite this, less than 10% of patients who could benefit from cutting-edge heart therapies receive them.
MHI Foundation runs four programs: Research, Equipment and Technology, Prevention, and Education. In F2025, MHI Foundation granted $34.1m to MHI.
Research was the largest program in F2025. It accounted for $26.9m or 79% of program spending. MHI Foundation grants money to the Research Centre of the Montreal Heart Institute, which houses basic, clinical, and preventive research. Research areas include women's heart health, arrhythmias during pregnancy, and precision medicine.
Equipment and Technology accounted for $3.4m or 10% of program spending in F2025. MHI Foundation does not report outputs for this program.
Prevention accounted for $2.0m or 6% of program spending in F2025. MHI Foundation grants money to the Évaluation, Prévention et Interventions en santé Cardiovasculaire (EPIC) Centre. The EPIC Centre provides personalized guidance to patients who want to maintain or improve their heart health.
Education accounted for $1.7m or 5% of program spending in F2025. MHI Foundation grants money to train health care professionals at MHI.
My anchor
Results and Impact
In 2023, the United States Food and Drug Administration approved colchicine for heart disease treatment. Colchicine is an anti-inflammatory drug used to treat gout. The approval was based on the COLCOT study conducted at MHI. The study found that colchicine reduces the risk of heart attacks and strokes.
MHI patients implanted with a HeartMate 3 LVAD have a 90% one-year survival rate since 2017. A HeartMate 3 LVAD is a mechanical pump that helps a failing heart pump blood.
Heart transplant patients at MHI have a 3-year survival rate of 92%, exceeding international standards.
Montreal Heart Institute Foundation's goal is to reduce mortality from heart disease by 30% by 2030.
While Ci highlights these key results, they may not be a complete representation of Montreal Heart Institute Foundation’s results and impact. This charity is not yet rated on impact. This shows as n/r and does not affect its star rating.
My anchor
Finances
Montreal Heart Institute Foundation had total revenues of $40.5m in F2025. Donations accounted for $27.0m or 67% of revenues. Investment income was $11.2m or 28% of revenues. In F2025, MHI Foundation spent $34.1m on grants to MHI. This was 84% of total revenues.
In F2025, administrative costs were $2.0m or 7% of revenues (less investment income). Fundraising costs were $4.7m or 16% of donations. For every dollar donated to the Foundation, 77 cents are available to go to the cause. This is within Ci’s reasonable range.
In F2025, the Foundation had $142.6m in cash and investments. This includes $113.9m of donor-endowed funds. Excluding donor-endowed funds, the Foundation’s reserves can cover a year of its annual grants. This is within Ci’s reasonable range.
In F2025, the Foundation paid $355k in professional and consulting fees. This was 10% of total compensation.
Profile updated by Raihan Firosh on June 22, 2026. Comments and corrections may be forthcoming.
Financial Review
Fiscal year ending March
|
2025 | 2024 | 2023 |
|---|---|---|---|
| Administrative costs as % of revenues | 6.8% | 4.7% | 13.4% |
| Fundraising costs as % of donations | 16.2% | 15.6% | 8.0% |
| Total overhead spending | 23.0% | 20.3% | 21.4% |
| Program cost coverage (%) | 101.2% | 190.7% | 217.8% |
Summary Financial StatementsAll figures in $000s |
2025 | 2024 | 2023 |
|---|---|---|---|
| Donations | 27,048 | 25,480 | 20,675 |
| Special events | 2,276 | 2,286 | 2,050 |
| Investment income | 11,197 | 9,238 | (295) |
| Total revenues | 40,521 | 37,004 | 22,430 |
| Grants | 34,058 | 25,547 | 21,735 |
| Administrative costs | 1,996 | 1,298 | 3,049 |
| Fundraising costs | 4,746 | 4,342 | 1,812 |
| Total spending | 40,800 | 31,186 | 26,595 |
| Cash flow from operations | (279) | 5,818 | (4,166) |
| Capital spending | 0 | 0 | 0 |
| Funding reserves | 142,581 | 143,698 | 134,217 |
Note: 1. Ci used T3010 data to allocate salaries expense between fundraising and administrative costs. This did not affect total expenses.
Salary Information
$350k + |
1 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
1 |
$160k - $200k |
1 |
$120k - $160k |
5 |
$80k - $120k |
2 |
$40k - $80k |
0 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2025
My anchor
Comments & Contact
Comments added by the Charity:
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 514-376-3330